바이오테크놀로지 기기 시장 : 부문별 예측(2025-2030년)

The Biotechnology Instrumentation Market was valued at USD 24.19 billion in 2023, expected to reach USD 26.49 billion in 2024, and is projected to grow at a CAGR of 9.84%, to USD 46.67 billion by 2030.

The biotechnology instrumentation market encompasses a wide array of devices and tools essential for the research, development, and application of biotechnology. These include instruments for genomics, proteomics, cell biology, and diagnostic testing. The necessity of these instruments stems from the growing demand for advanced technologies in healthcare, pharmaceuticals, and agriculture to address complex biological challenges, such as disease diagnosis, drug discovery, and genetic modification. Biotech instruments are utilized in various applications, such as sequencing, imaging, chromatography, and spectroscopy, with end-use in medical research institutions, pharmaceutical companies, and laboratories.

Market growth is influenced by factors such as advancements in molecular biology techniques, increased funding for biotech research, and the rising demand for personalized medicine. Emerging opportunities lie in the development of cost-effective, portable, and high-throughput devices, as well as integrating AI and machine learning to enhance data analysis capabilities. There is also a growing market for instruments that cater to the development of biologics and biosimilars, driven by the expiration of patents for several biologic drugs.

Challenges in the market include high costs associated with advanced instrumentation, the intricate regulatory environment, and the need for highly skilled personnel to operate these complex devices. Furthermore, the rapid pace of technological change can outdate existing instruments quickly, posing a risk of obsolescence.

Innovation is ripe in fields such as miniaturization of devices, development of lab-on-a-chip technologies, and enhancement of biosensor sensitivity and specificity. Research focusing on reducing instrument costs and improving the accuracy and speed of biotechnological assays offers further growth opportunities.

The biotech instrumentation market is dynamic and competitive, characterized by continuous advancements and a strong emphasis on research and development. Companies that can navigate regulatory landscapes, cater to evolving end-user demands, and leverage technological innovations are well-positioned to capitalize on growth potential and sustain their market relevance.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biotechnology Instrumentation Market

The Biotechnology Instrumentation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Continuous rise in prevalence of diseases and need for effective treatments
  • Growing adoption of portable point-of-care diagnostic devices
  • Improved healthcare spending and infrastructure across economies
• Market Restraints
  • Initial high costs associated with implementation of biotechnology instruments
• Market Opportunities
  • Growing advancements in lab automation instruments
  • Emerging investments in genomic research projects and startups
• Market Challenges
  • Stringent regulatory requirements and validation processes

Porter's Five Forces: A Strategic Tool for Navigating the Biotechnology Instrumentation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biotechnology Instrumentation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biotechnology Instrumentation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biotechnology Instrumentation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biotechnology Instrumentation Market

A detailed market share analysis in the Biotechnology Instrumentation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biotechnology Instrumentation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biotechnology Instrumentation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Biotechnology Instrumentation Market

A strategic analysis of the Biotechnology Instrumentation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Biotechnology Instrumentation Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Alcon Scientific, Azenta Life Sciences, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Bruker Corporation, Danaher Corporation, Endress+Hauser Group Services AG, F. Hoffmann-La Roche Ltd., GE HealthCare Technologies Inc., HORIBA, Ltd., Hudson Robotics, Illumina, Inc., JASCO, Lumentum Holdings Inc., Merck KGaA, Oxford Nanopore Technologies PLC, PerkinElmer U.S. LLC, Qiagen GmbH, Quest Diagnostics Incorporated, Sartorius AG, Shimadzu Corporation, Siemens Healthcare GmbH, Tecan Trading AG, Thermo Fisher Scientific Inc., and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Biotechnology Instrumentation Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Bioreactors, Centrifuges, Electrophoresis, Immunoassay, Incubators, Liquid Chromatography, Mass Spectrometry, Next Generation Sequencing, and Spectrophotometers.
• Based on End-User, market is studied across Biotechnology & Biopharmaceutical Companies, Clinical Research Organizations (CROs), and Government & Academic Institutes.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Continuous rise in prevalence of diseases and need for effective treatments
    • 5.1.1.2. Growing adoption of portable point-of-care diagnostic devices
    • 5.1.1.3. Improved healthcare spending and infrastructure across economies
  • 5.1.2. Restraints
    • 5.1.2.1. Initial high costs associated with implementation of biotechnology instruments
  • 5.1.3. Opportunities
    • 5.1.3.1. Growing advancements in lab automation instruments
    • 5.1.3.2. Emerging investments in genomic research projects and startups
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory requirements and validation processes
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Biotechnology Instrumentation Market, by Product

• 6.1. Introduction
• 6.2. Bioreactors
• 6.3. Centrifuges
• 6.4. Electrophoresis
• 6.5. Immunoassay
• 6.6. Incubators
• 6.7. Liquid Chromatography
• 6.8. Mass Spectrometry
• 6.9. Next Generation Sequencing
• 6.10. Spectrophotometers

7. Biotechnology Instrumentation Market, by End-User

• 7.1. Introduction
• 7.2. Biotechnology & Biopharmaceutical Companies
• 7.3. Clinical Research Organizations (CROs)
• 7.4. Government & Academic Institutes

8. Americas Biotechnology Instrumentation Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Biotechnology Instrumentation Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Biotechnology Instrumentation Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Agilent Technologies, Inc.
• 3. Alcon Scientific
• 4. Azenta Life Sciences
• 5. Becton, Dickinson and Company
• 6. Bio-Rad Laboratories, Inc.
• 7. bioMerieux SA
• 8. Bruker Corporation
• 9. Danaher Corporation
• 10. Endress+Hauser Group Services AG
• 11. F. Hoffmann-La Roche Ltd.
• 12. GE HealthCare Technologies Inc.
• 13. HORIBA, Ltd.
• 14. Hudson Robotics
• 15. Illumina, Inc.
• 16. JASCO
• 17. Lumentum Holdings Inc.
• 18. Merck KGaA
• 19. Oxford Nanopore Technologies PLC
• 20. PerkinElmer U.S. LLC
• 21. Qiagen GmbH
• 22. Quest Diagnostics Incorporated
• 23. Sartorius AG
• 24. Shimadzu Corporation
• 25. Siemens Healthcare GmbH
• 26. Tecan Trading AG
• 27. Thermo Fisher Scientific Inc.
• 28. Waters Corporation